{"id":"W2805806091","doi":"10.1016/j.cgh.2018.05.026","title":"Rapid Response to Vedolizumab Therapy in Biologic-Naive Patients With Inflammatory Bowel Diseases","year":2018,"lang":"en","type":"article","venue":"Clinical Gastroenterology and Hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"Takeda Pharmaceutical Company; Takeda Pharmaceuticals U.S.A.","keywords":"Vedolizumab; Medicine; Internal medicine; Placebo; Ulcerative colitis; Gastroenterology; Inflammatory bowel disease; Post-hoc analysis; Crohn's disease; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002619641,0.0002706159,0.001125098,0.0003451992,0.0002389833,0.0004068305,0.0002413879,0.0003334443,0.001085153],"category_scores_gemma":[0.003828695,0.0001747428,0.0008760318,0.000306352,0.0002086946,0.0004263418,0.0002374043,0.0005237599,0.0001158687],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003065256,"about_ca_system_score_gemma":0.0002964646,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000220607,"about_ca_topic_score_gemma":0.0006133622,"domain_scores_codex":[0.9982509,0.0009499362,0.0002015165,0.0002394514,0.0002269746,0.000131318],"domain_scores_gemma":[0.996556,0.001424286,0.001400251,0.0001172428,0.000159247,0.000343021],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08261133,0.00165733,0.8140637,0.0007288062,0.001652187,0.0004356107,0.0002031429,0.001310615,0.01266135,0.0001148349,0.0007656355,0.08379544],"study_design_scores_gemma":[0.005254972,0.02584166,0.9628532,0.00006180245,0.0005611558,0.0007574512,0.00009812884,0.001213812,0.001599203,0.0001235724,0.001607868,0.00002723801],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958417,0.003148017,0.0002303198,0.0000925314,0.00002180388,0.00006931604,0.000187339,0.000007638918,0.0004014087],"genre_scores_gemma":[0.9984774,0.0004653214,0.0004224598,0.0001042708,0.00004319703,0.00006642861,0.0003068343,0.000002126744,0.0001120158],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002619641,"threshold_uncertainty_score":0.01385415,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01319386288923481,"score_gpt":0.2789419544049325,"score_spread":0.2657480915156977,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}